WuXi PharmaTech Becomes the Largest Beilstein Customer

WuXi PharmaTech Becomes the Largest Beilstein Customer

March 17, 2006

   
    SHANGHAI, China, March 17 /Xinhua-PRNewswire/ -- WuXi
PharmaTech is pleased to announce today that it has signed
agreements with NeoTrident Technology and Elsevier MDL to
significantly increase the user seats of CrossFire
Beilstein and MDL Patent Chemistry Database platforms,
effectively making WuXi PharmaTech the largest Beilstein
industry customer in China.  WuXi PharmaTech also has
substantially increased the number of installed MDL
ISIS/Base, ISIS/Draw and ISIS for Excel, software for
better compound and database management.

    (Logo:
http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) 

  
    The CrossFire Beilstein database is the world's largest
compilation of chemical facts and the MDL Patent Chemistry
Database indexes chemical reactions, substances and
substance related information from organic chemistry and
life sciences patent publications.  These databases are
indispensable in generating new leads, planning synthetic
routes, determining bioactivity and physical properties.

    Making Elsevier MDL chemistry databases widely
accessible to chemists will greatly improve the overall
drug discovery and development productivity and quality at
WuXi PharmaTech.  The installation of the two databases
also exemplifies WuXi PharmaTech's commitment to IP
protection.  Unofficial and unregistered chemistry software
and databases use remains prevalent and unchecked in China. 
As the staunchest IP protection champion, WuXi PharmaTech is
well recognized by its collaboration partners for setting
high IP standards in China. 

    "As China's world-class drug discovery and
development services company, WuXi PharmaTech has been the
staunchest IP protection champion in China from its
inception, therefore we are very pleased to work with
it."  Mr. Lingxiao Cao, General Manager of NeoTrident
Technology said.

    Dr. Ge Li, Chairman and CEO of WuXi PharmaTech said,
"The agreements with NeoTrident and Elsevier MDL give
us state-of-the-art chemistry databases. Having scientific
and technical information conveniently available to our
scientists is essential in providing high quality research
work to our clients.  Engaging content provider like
Elsevier MDL shows our unwavering commitment to quality,
integrity and IP protection."

    About WuXi PharmaTech

    Founded in 2001, the Shanghai-based WuXi PharmaTech
Co., Ltd., is the leader in the pharmaceutical R&D
services industry in China.  WuXi PharmaTech assists global
pharmaceutical and biopharmaceutical companies in shortening
the cycle and lowering the cost of drug research and
development, and helps clients fully leverage the lower
cost R&D capacity in China.

    As an integrated drug R&D outsourcing service
company, WuXi PharmaTech provides discovery and development
services to our partners from lead identification to
pre-clinical through our state-of-the-art facilities.  The
company has a broad service spectrum ranging from lead
generation and optimization, in vivo and in vitro ADMET
profiling, bioanalytical services, to chemistry process
development and large scale manufacturing.  There are over
750 scientific staff members and its management team
consists of veterans from U.S., India and Japan
pharmaceutical industry.  WuXi PharmaTech has a 360,000 sq.
ft. state-of-the-art research center in WaiGaoQiao Free
Trade Zone and a 250,000 sq. ft. and ISO 9001:2000
certified GMP plant in Jinshan Chemical Industry
Development Zone, Shanghai.  The company's customers
include 19 of the top 20 pharmaceutical companies and 8 of
the top 10 biopharmaceutical companies in the world.
 
    About NeoTrident Technology Ltd. 

    NeoTrident ( http://www.neotrident.com ) is the leading
Informatics solutions company in the fields of biological
and material sciences in China.  NeoTrident systematically
provides molecular modeling technological products,
comprehensive chemical information and workflow managing
platforms as well as professional chemical information and
intelligence services, respectively.  With the business
headquarter firmly rooted in Beijing, NeoTrident branches
its technology support and research center in Shanghai, and
running center in Hong Kong.  NeoTrident has over 300
customers in China, among which include the largest
pharmaceutical companies in China, the best new drug
research CROs (contract research organization), the most
famous petroleum giants and all the main universities and
research institutions.
 
    About Elsevier MDL

    Elsevier MDL provides informatics, database and
workflow solutions that accelerate successful life sciences
R&D by improving the speed and quality of scientists'
decision making.  Researchers around the world depend on
Elsevier MDL for innovative and reliable discovery
informatics software solutions and services augmented by
400 Elsevier chemistry and life sciences journals and
related products.  For more information, visit
http://www.mdl.com .  Elsevier is a world-leading publisher
of scientific, technical and medical information products
and services.  For more information, visit
http://www.elsevier.com .
 
    For more information, please contact: 

     David Yin, Public Relations
     WuXi PharmaTech Co., Ltd.
     Tel:   [phone]
     Email: [e-mail]

SOURCE  WuXi PharmaTech Co., Ltd.